2 The initiation of dialysis

Nephrology Dialysis Transplantation

Volumn 20, Issue SUPPL. 9, 2005, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEPATITIS B VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; UREA;

ANEMIA; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CONSERVATIVE TREATMENT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIET THERAPY; EUROPE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEPATITIS B; HUMAN; HYDRATION; HYPERTENSION; INFLUENZA; MALNUTRITION; METABOLIC ACIDOSIS; NOTE; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEINURIA; RENAL OSTEODYSTROPHY; STREPTOCOCCUS INFECTION; TREATMENT PLANNING; UREA BLOOD LEVEL; UREMIA;

EID: 27944492809     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi1116     Document Type: Note

References (68)

1. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41 (C)
2. Mirahmadi MK, Byrne C, Burton C, Penera N, Gordon S, Vaziri ND. Prediction of creatinine clearance from serum creatinine in spinal cord injury patients. Paraplegia 1983; 21: 23-29 (B)
3. Quan A, Adams R, Ekmark E, Baum M. Serum creatinine is a poor marker of glomerular filtration rate in patients with spina bifida. Dev Med Child Neurol 1997; 39: 808-810 (B)
4. Coccetto DM, Tschanz C, Bjornsson TD. Decreased rate of creatinine production in patients with hepatic disease: Implications for estimation of creatinine clearance. Ther Drug Monit 1983; 5: 161-168 (B)
5. Delanghe JR, Lanagie HK, De Buyzere ML, Leroux-Roels GC. Glomerular filration rate and creatinine production in adult icteric patients. Clin Chim Acta 1994; 222: 33-44 (C)
6. Caregaro L, Menon F, Angeli P et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 1994; 154: 201-205 (C)
7. Orlando R, Floreani M, Padrini R, Palatini P. Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis. Clin Nephrol 1999; 51: 341-347 (C)
8. Spencer K. Analytical reviews in clinical biochemistry: The estimation of creatinine. Ann Clin Biochem 1986; 23: 1-25 (C)
9. Mayersohn M, Conrad KA, Achari R. The influence of a cooked meat meal on creatinine plasma concentration and creatinine clearance. Br J Clin Pharmacol 1983; 15: 227-230 (C)
10. Adey D, Kumar R, McCarthy JT, Nair KS. Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol 2000; 278: E219-E225 (A)
11. Gates GF. Creatinine clearance estimation from serum creatinine values: an analysis of three mathematical models of glomerular function. Am J Kidney Dis 1985; 5: 199-205 (C)
12. Shemesh O, Golbetz H, Kries JP, Meyers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28: 830-838 (B)
13. Jones JD, Burnet PC. Creatinine metabolism in humans with decreased renal function: Creatinine deficit. Clin Chem 1974; 28: 1204-1212 (C)
14. Mitch WE, Collins VU, Walser M. Creatinine metabolism in chronic renal failure. Clin Sci 1980; 58: 327-335 (N.A.)
15. Hankins DA, Babb AL, Uvelli DA, Scribner BH. Creatinine degradation I: the kinetics of creatinine removal in patients with chronic kidney disease. Int J Artif Organs 1981; 4: 35-39 (C)
16. Perrone RD, Madius NE, Levey AS. Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 1992; 38: 1933-1953 (N.A.)
17. Bauer JH, Brooks CS, Burch RN. Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 1982; 2: 337-346 (C)
18. Van Acker BAC, Koomen GCM, Koopman MG, De Waart DR, Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 1992; 340: 1326-1329 (B)
19. Toto RD. Conventional measurement of renal function utulizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance. Curr Opin Nephrol Hypertens 1995; 4: 504-509 (N.A.)
20. Walser M. Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis 1998; 32: 23-31 (C)
21. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470 (A)
22. Van Acker BAC, Koomen GCM, Koopman MG, Krediet RT, Arisz L. Discrepancy between circadian rhythms of inulin and creatinine clearance. J Lab Clin Med 1992; 120: 400-410 (B)
23. Roubenoff R, Drew H, Moyerr M et al. Oral cimetidine improves the accuracy and precision of creatinine clearance in lupus nephritis. Ann Intern Med 1990; 1134: 501-506 (A)
24. Hilbrands LB, Artz MA, Wetzels JFM, Koene RAP. Cimetidine improves the reliability of creatinine as a marker of glomerular filtration. Kidney Int 1991; 40: 1171-1176 (A)
25. Hirata-Dulas CAI, Halsenson CE, Kasiske BL. Improvement in accuracy and precision of creatinine clearance as a measure of glomerular filtration rate with oral cimetidine in renal transplant patients. Clin Transplant 1993; 7: 552-558 (A)
26. Zaltzman JS, Whiteside C, Cattran DC, Lopez FM, Logan AC. Accurate measurements of impaired glomerular filtration using single-dose oral cimetidine. Am J Kidney Dis 1996; 27: 504-511 (B)
27. Van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with CAPD. J Am Soc Nephrol 1996; 7: 745-750 (B)
28. Milutinovic J, Cutler RE, Hoover P, Meijsen B, Scribner BH. Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int 1975; 8: 185-190 (B)
29. Churchill DN, Taylor DW, Keshaviah PR for the CANUSA peritoneal dialysis study group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198-207 (B)
30. Korevaar JC, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis. Adv Perit Dial 1999; 15: 132-137 (B)
31. Kemperman FAW, Krediet RT, Arisz L. Formula-derived prediction of the glomerular filtration rate from plasma creatinine concentration. Nephron 2002; 91: 547-558 (N.A.)
32. Levey AS, Adder S, Caggiula, AW et al. Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol 1996; 7: 2616-2626 (A)
33. Hannedouche T, Chauveau P, Kalou F et al. Factors affecting progression in advanced chronic renal failure. Clin Nephrol 1993; 39: 312-320 (B)
34. Jungers P, Hannedouche T, Itakura Y et al. Progression rate to end-stage renal failure in non-diabetic kidney diseases: A multivariate analysis of determinant factors. Nephrol Dial Transplant 1995; 10: 1353-1360 (B)
35. Locatelli F, Alberti D, Graziani G et al. Factors affecting chronic renal failure progression: Results from a multicentre trial. The Northern Italian Cooperative Study Group. Miner Electrolyte Metab 1992; 18: 295-302 (B)
36. Crepaldi G, Carta Q, Deferrari G et al. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. Diabetes Care 1998; 21: 104-110 (A)
37. Giatras I, Lau J, Levey AS. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med 1997; 127: 337-345 (A)
38. Maschio G, Alberti D, Janin G et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. Thel Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996; 334: 939-945 (A)
39. Toto RD, Mitchell HC, Smith RD et al. 'Strict' blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int 1995; 48: 851-859 (B)
40. Kamper AL, Strandgaard S, Leyssac PP. Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial. Am J Hypertens 1992; 5: 423-430 (B)
41. Ruggenenti P, Perna A, Benini R et al. In chronic nephropathies prolonged ACE inhibition can induce remission: Dynamics of time-depeodent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia. J Am Soc Nephrol 1999; 10: 997-1006 (B)
42. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853 (A)
43. Acher CW, Belzer FO, Grist TM et al. Late renal function in patients undergoing renal revascularization for control of hypertension and/or renal preservation. Cardiovasc Surg 1996; 4: 602-606 (C)
44. Hansen KJ, Lundberg AH, Benjamin ME et al. Is renal revascularization in diabetic patients worthwhile? J Vasc Surg 1996; 24: 383-392 (C)
45. Reilly JM, Rubin BG, Thompson RW et al. Revascularization of the solitary kidney: A challenging problem in a high risk population. Surgery 1996; 120: 732-736 (C)
46. van Damme H, Jeusette F, Pans A et al. The impact of renal revascularisation on renal dysfunction. Eur J Vasc Endovasc Surg 1995; 10: 330-337 (C)
47. Cappelli P, Evangelista M, Bonomini M, Palmieri PF, Albertazzi A. Lipids in the progression of chronic renal failure. Nephron 1992; 62: 31-35 (B)
48. Regalado M, Yang S, Wesson DE. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 2000; 35: 687-694 (B)
49. Korte W, Cogliatti SB, Jung K, Riesen W. Mild renal dysfunction is sufficient to induce erythropoietin deficiency in patients with unexplained anaemia. Clin Chim Acta 2000; 292: 149-154 (B)
50. Hayashi T, Suzuki A, Shoji T et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 2000; 35: 250-256 (B)
51. Amann K, Rychlik I, Miltenberger-Milteny G, Ritz E. Left ventricular hypertrophy in renal failure. Kidney Int Suppl 1998; 68: S78-S85 (B)
52. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347-354 (B)
53. Tucker B, Fabbian F, Giles M et al. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant 1997; 12: 724-728 (B)
54. Martinez I, Saracho R, Montenegro J, Llach F. The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 1997; 29: 496-502 (C)
55. Nand N, Aggarwal HK, Anupam, Sharma M. Effect of protein and phosphate restricted and calcium and alphacalcidol supplemented diet on renal and parathyroid functions and protein status in chronic renal failure patients. J Assoc Physicians India 1999; 47: 869-873 (C)
56. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911 (B)
57. Kopple JD, Berg R, Houser H, Steinman TI, Teschan P. Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl 1989; 27: S184-S194 (A)
58. Lusvarghi E, Fantuzzi AL, Medici G, Barbi L, D'Amelio A. Natural history of nutrition in chronic renal failure. Nephrol Dial Transplant 1996; 11 [Suppl 9]: 75-84 (B)
59. Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 1995; 6: 1386-1391 (B)
60. Massy ZA, Khoa TN, Lacour B et al. Dyslipidaemia and the progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant 1999; 14: 2392-2397 (B)
61. Dukes CS, Street AC, Starling JF, Hamilton JD. Hepatitis B vaccination and booster in predialysis patients: A 4-year analysis. Vaccine 1993; 11: 1229-1232 (A)
62. Ortbals DW, Marks ES, Liebhaber H. Influenza immunization in patients with chronic renal disease. J Am Med Assoc 1978; 239: 2562-2565 (B)
63. Fuchshuber A, Kuhnemund O, Keuth B et al. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol Dial Transplant 1996; 11: 468-473 (B)
64. NKF-DOQI. Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. National Kidney Foundation, New York; 1997: 18-20 (N.A.)
65. Bonomini V, Feletti C, Scolari MP, Stefoni S. Benefits of early initiation of dialysis. Kidney Int Suppl 1985; 17: S57-S59 (C)
66. Tattersall J, Greenwood R, Farrington K. Urea kinetics and when to commence dialysis. Am J Nephrol 1995; 15: 283-289 (C)
67. Korevaar JC, Jansen MAM, Dekker FW et al. When to initiate dialysis: effect of proposed US guidelines on survival Lancet 2001; 358: 1046-1050 (B)
68. Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG. Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 2002; 13: 2125-2132 (B)